Ross Feller Casey today filed a lawsuit against the makers of two popular testosterone-containing drugs, Testim and AndroGel, alleging that they caused severe heart damage in a Scranton man that required bypass surgery.
It brings to three the number of testosterone lawsuits brought in Philadelphia by Ross Feller Casey in the past two weeks alone.
The latest suit was filed on behalf of Robert Olivetti, 60, and his wife Marion of Scranton, against Auxilium Pharmaceuticals, Inc., the makers of Testim, and Abbott Laboratories and AbbVie, Inc., the makers of AndroGel.
Olivetti, 60, had taken Testim from 2007 until 2012, and then was subsequently placed on AndroGel for several months until he was diagnosed with heart damage, multi-vessel coronary artery disease and depressed left ventricular function—a condition that required bypass surgery.
The suit alleges that the heart condition was “directly and proximately caused by, or had the risk of harm increased by, jointly and severally, the testosterone-containing topically applied medications Testim and AndroGel.”
Ross Feller Casey has filed two earlier suits in Philadelphia alleging that Testim caused an Alabama man to suffer a stroke and a New Jersey man to have a heart attack.
Like those suits, today’s latest action accuses the pharmaceutical companies of knowing that their drug was dangerous, failing to provide adequate safety warnings and instructions, and for using deceptive marketing techniques.
The testosterone lawsuits are believed to be the first and to date only ones brought in Philadelphia, and among only a very few filed nationwide.
Ross Feller Casey is currently investigating many other reports from men across the nation who have suffered severe cardiovascular and cerebrovascular events while on AndroGel, Testim, Axiron, AndroDerm, Fortesta, and other so-called “Low T” replacement therapies. The firm expects to bring other “Low T” lawsuits in the coming weeks.
For more information, visit http://www.rossfellercasey.com/practice-areas/lowtlawsuit/